WallStreetZenWallStreetZen

NASDAQ: AGEN
Agenus Inc Stock Forecast, Predictions & Price Target

Analyst price target for AGEN

Based on 2 analysts offering 12 month price targets for Agenus Inc.
Min Forecast
$100.00+1,247.71%
Avg Forecast
$130.00+1,652.02%
Max Forecast
$160.00+2,056.33%

Should I buy or sell AGEN stock?

Based on 2 analysts offering ratings for Agenus Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AGEN stock forecasts and price targets.

AGEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-18
lockedlocked$00.00+00.00%2024-03-14

1 of 1

Forecast return on equity

Is AGEN forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AGEN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

AGEN revenue forecast

What is AGEN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$275.4M+76.16%
Avg 2 year Forecast
$186.8M+19.52%
Avg 3 year Forecast
$287.9M+84.19%
AGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AGEN revenue growth forecast

How is AGEN forecast to perform vs Biotechnology companies and vs the US market?
Company
22.58%
Industry
37.5%
Market
10.08%
AGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AGEN$7.42$130.00+1,652.02%Strong Buy
ACHV$4.54$16.33+259.76%Strong Buy
ACET$1.88$11.33+504.43%Strong Buy
CAPR$5.04$24.00+376.19%Strong Buy
CRVO$24.60$65.00+164.23%Strong Buy

Agenus Stock Forecast FAQ

Is Agenus Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: AGEN) stock is to Strong Buy AGEN stock.

Out of 2 analysts, 1 (50%) are recommending AGEN as a Strong Buy, 1 (50%) are recommending AGEN as a Buy, 0 (0%) are recommending AGEN as a Hold, 0 (0%) are recommending AGEN as a Sell, and 0 (0%) are recommending AGEN as a Strong Sell.

If you're new to stock investing, here's how to buy Agenus stock.

What is AGEN's revenue growth forecast for 2024-2026?

(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of 22.58% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Agenus's revenue in 2024 is $156,314,000.On average, 4 Wall Street analysts forecast AGEN's revenue for 2024 to be $5,767,691,661, with the lowest AGEN revenue forecast at $2,844,467,343, and the highest AGEN revenue forecast at $13,183,414,918. On average, 4 Wall Street analysts forecast AGEN's revenue for 2025 to be $3,913,279,089, with the lowest AGEN revenue forecast at $3,024,602,978, and the highest AGEN revenue forecast at $5,267,920,006.

In 2026, AGEN is forecast to generate $6,030,815,364 in revenue, with the lowest revenue forecast at $3,673,929,102 and the highest revenue forecast at $8,636,037,449.

What is AGEN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: AGEN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is AGEN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year AGEN price target, the average AGEN price target is $130.00, with the highest AGEN stock price forecast at $160.00 and the lowest AGEN stock price forecast at $100.00.

On average, Wall Street analysts predict that Agenus's share price could reach $130.00 by Mar 18, 2025. The average Agenus stock price prediction forecasts a potential upside of 1,652.02% from the current AGEN share price of $7.42.

What is AGEN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: AGEN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.